|November 15, 2011|
The world’s first official trial using human embryonic stem cells in patients has been halted.
Geron, based in California, made the sudden announcement that it was halting further work in this field.
In a statement the company said in the “current environment of capital scarcity and uncertain economic conditions” it had decided to concentrate instead on developing cancer treatments.
Geron said it was seeking partners to enable further development of its stem cell programmes. The press statement implies the decision is purely a financial one – by stopping its stem cell programme it will cut its workforce by more than a third and save millions of dollars.
Geron Abandons Stem Cell Research, Nature News Blog
Geron Quits Stem Cell Research; Move Deemed Setback to Field, CA SC Report Blog
First Test of Human Embryonic Stem Cell Therapy Discontinued, Washington Post